Flavoxate Hydrochloride Tablets Market to Witness Significant Growth, Owing to High Prevalence of Urinary Incontinence

 

Flavoxate Hydrochloride Tablets Market

Flavoxate HCL is a synthetic urinary tract spasmolytic used to treat bladder symptoms such as frequent or urgent urination, increased nighttime urination, bladder pain, and incontinence (urine leakage). According to International Continence Society, in 2018, 63 million people suffered from urgency urinary incontinence worldwide. Such high prevalence of incontinence is expected to aid in growth of the flavoxate hydrochloride tablets market.

High prevalence of urinary tract infections (UTIs) is also expected to aid in growth of the flavoxate hydrochloride tablets market. According to the study “Prevalence of Bacterial Urinary Tract Infections and Associated Factors among Patients Attending Hospitals in Bushenyi District, Uganda”, published in February 2019, the prevalence of UTI was 32.2% among the study. Flavoxate HCL is commonly used to treat conditions such as prostatitis, UTIs, and incontinence. The active ingredient is flavonoid glycoside A, which helps by reducing urine flow. The reduced flow enables bacteria that normally live in the bladder to be flushed out with urine.

Flavoxate HCL is sold as Urispas in the flavoxate hydrochloride tablets market.  It is a complex synthetic amino acid that acts by interfering with specific uric acid-producing enzymes in the urinary bladder. It relieves pain, inflammation, urgency, bladder swelling, flatulence, and urinary frequency in most patients with kidney disease (check with your doctor for medical guidance about the proper treatment for your condition). The medication also can effectively prevent the production of new stones in the urinary bladder or reduce the frequency of urination.

The global flavoxate hydrochloride tablets market is expected to witness significant growth during 2020-2027. Increasing geriatric population is one of the major factors for growth of the market during the forecast period. According to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050.   Several companies are involved in the production and distribution of these tablets. Cipla Inc. is one of the major players in the global market. Their manufacturing facilities are located in North America and Europe. Perrigo Company PLC is another manufacturer that produces and distributes this product. Other companies that operate in the market are Epic Pharma LLC, Recordati S.p.A, Manus Aktteva Biopharma LLP, Trumac Healthcare, Taj Pharmaceuticals Ltd., Zhejiang CONBA Pharmaceutical co., ltd., and Walter Bushnell.


Location: India

Comments

Post a Comment

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

Image
  Fitness equipment is any mechanical device or equipment used in sport or exercise to improve the physical performance or strength of that activity by providing either adjustable or constant levels of force, either of dynamic nature that is immediately available to exert (such as running) or of a static type that requires adjustments (such as a bicycle). Some common types of equipment are treadmills, elliptical machines, step machines, exercise bicycles, recumbent bikes, treadmill monitors, rowing machines, and many more. Fitness equipment is used in gyms and private home fitness facilities as well as public parks and recreational facilities. Fitness equipment for the home is designed to provide low-impact aerobic workouts. Some items are available for rent or sale on the Internet. Rowing machines and exercise bicycles can give an all-over body workout, while Schwinn exercise bicycles can be used to target specific muscles. Fitness equipment for home gyms can be classified into ...
Read more

Pressure Bandages Market : Global Industry Analysis and Opportunity Assessment

Image
  Pressure bandages are clinical gadgets used to ensure and mend a harmed region and to control draining without influencing the ordinary blood dissemination. Pressure bandages include non-follower bandages applied over an entry point or wound and is covered by spongy stretchable cement. They are basically used to pack the dead space at the site of injury or cut and forestall the arrangement of seroma and hematoma. Pressure bandages have wide applications in various clinical regions, for example, leg ulcers, muscular medical procedures, and the executives of persistent just as intense injuries, lymphedema, musculoskeletal wounds, and so forth Various sorts of pressure bandages, for example, low flexibility bandages, versatile bandages, and multicomponent multi-facet pressure bandages are accessible in the market and have explicit applications in various clinical signs. To get most extreme market share, driving organizations in the worldwide pressure bandages market have begun pr...
Read more

Botanical and Plant Derived Drugs Market by Source,Dosage - Global Industry Analysis,Size,Share

Image
The U.S. Food and Drug Administration's (FDA) organic medication pathway is as yet being refined as additional medication competitors keep on entering the clinical improvement pipeline under what many think about a simpler way to commercialization. FDA endorsement, a moderately rigid cycle by worldwide principles, by and large makes the way for endorsement in different nations. Further, the U.S. is viewed as a highest quality level for administrative survey. The worldwide market for organic and plant-determined medications Expected to develop around $39.6 billion by 2022 with a build yearly development rate (CAGR) of 6.1% This report is a scientific business instrument whose basic role is to depict the botanical and plant derived drugs market with the general plant-inferred drug industry as a scenery and the worldwide market for these medications going ahead. For the reasons for this report, botanicals are those medications that are FDA-endorsed under the plant drug pathway,...
Read more